+1 888-880-9539News by Industry Error
- Unfortunately, the press release you are looking for is not available. Please see below for a list of similar stories that may be of interest to you.
News by Industry
Cancer
3363 news stories found
Press Release
September 28, 2010
New Heart Foundation founder Dr Wayne Franco believes that stem cells from developing tooth buds are key to treating autism, brain trauma, hyposic brain injuries and stroke. These priceless cells are readily available.
Read Press Release
Press Release
September 27, 2010
Ellen Cooperperson's Corporate Performance Consultants, Inc. (CPC) has been selected to lead the faculty of a groundbreaking project that will help 8,000 medical doctors to improve their interpersonal and communications skills
Read Press Release
Press Release
September 25, 2010
International Foundation, No Worries Now, which organizes proms for teens with life-threatening medical conditions, released an updated web site this week with the help of Conceptinet's web design and hosting services.
Read Press Release
Press Release
September 23, 2010
In spite of low vendor performance scores, few providers are looking to replace their current oncology systems in the near future
Read Press Release
Press Release
September 22, 2010
New doctors linked to 10% spike in deaths by medication error, greater supervision and training urged.
Read Press Release
Press Release
September 22, 2010
Study shows that people 65 and older are at higher risk of cataracts if taking SSRIs and SNRIs.
Read Press Release
Press Release
September 22, 2010
Global Health Progress agrees criticizing "Big Pharma" is not the answer.
Read Press Release
Press Release
September 20, 2010
Dr. Ershadi, director of the ANTIAGING Institute of California, has introduced a natural menopause cure that has proven to be beneficial in relieving symptoms of menopause, including the most common ones of night sweats, hot flashes and fatigue.
Read Press Release
Press Release
September 16, 2010
A study completed in the United Kingdom showed a large number of DePuy ASR Hip Replacement Systems experienced failure within the first five years of operation, and was the basis for the DePuy hip recall.
Read Press Release
Press Release
September 16, 2010
DePuy hip lawsuits are being filed on behalf of patients nationwide that are affected by the DePuy hip recall.
Read Press Release
Press Release
September 15, 2010
Depuy hip recall lawyers file DePuy hip lawsuits on behalf of patients nationwide affected by the DePuy hip recall.
Read Press Release
Press Release
September 15, 2010
Replica Farm will present Olympic Grand Prix Jumper "Sapphire", owned and ridden by Mark Watring of Thousand Oaks, California and his cloned colt "Saphir" in a historic display of cloned horses hosted by producer ViaGen, Inc. of Austin Texas.
Read Press Release
Press Release
September 15, 2010
Wear pink Snazzy Lites colorful clip-in hair extensions to show your commitment to finding a cure.
Read Press Release
Press Release
September 14, 2010
Genadyne Biotechnologies and The MED Group has agreed to a group purchasing agreement for the Negative Pressure Wound Therapy products.
Read Press Release
Press Release
September 10, 2010
Miles for Hope, a Clearwater charity, is holding their 3rd annual Moving Towards a Cure event to raise brain tumor awareness and funding for this deadly disease
Read Press Release
Press Release
September 10, 2010
Global Health Progress supports new drug development to combat "untouchable" diseases.
Read Press Release
Press Release
September 10, 2010
A recent clinical trial in Germany provided greater supporting evidence for the use of hyperthermia in cancer treatment, which the alternative cancer treatment center EuroMed offers to its patients.
Read Press Release
Press Release
September 8, 2010
KLAS announces five new members of the company's Advisory Board.
Read Press Release
Press Release
September 4, 2010
Global Health Progress supports MMV's decision to contribute its intellectual property.
Read Press Release
Press Release
September 4, 2010
Onyx Scientific manufacture high value intermediates and APIs to GMP-compliant standards for both phase I and phase II clinical studies.
Read Press Release